The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Radiation
Interventions: DEVICE: Prosigna
Sponsor: Dana-Farber Cancer Institute
Collaborators: NanoString Technologies, Inc.